What is the best treatment for endometriosis, and does the drospirenone‑only pill (Slynd) work?

Treatment of Endometriosis and Slynd (Drospirenone-Only Pill)

For endometriosis-associated pain, start with progestin-only pills as first-line therapy—Slynd (drospirenone 4 mg) is an effective and well-tolerated option that works for this indication.

First-Line Medical Management

Progestins are the preferred initial medical treatment for endometriosis-related pain 1. The evidence supports several options:

• Oral contraceptives (combined or progestin-only) are effective compared to placebo and may be equivalent to more costly regimens 1
• Depot medroxyprogesterone acetate is similarly effective 1
• Norethindrone acetate has regulatory approval and randomized controlled trial data supporting efficacy 2

Recent evidence suggests progestin-only pills may actually be superior to combined oral contraceptives as first-line therapy 2. Combined pills likely provide initial relief primarily through improvement in primary dysmenorrhea, but biologic data suggest potential adverse effects on long-term endometriosis progression 2.

Does Slynd Work for Endometriosis?

Yes, Slynd is effective for endometriosis. While Slynd (drospirenone 4 mg) is FDA-approved as a progestin-only contraceptive 3, emerging clinical data demonstrates its efficacy for endometriosis:

• In adolescents and young adults with endometriosis, 67% reported less pain and 52% achieved absence of bleeding/spotting when taking continuous drospirenone 4
• 84.6% of dysmenorrhea patients and 77.8% of pelvic pain patients reported resolution or improvement 5
• The medication was well-tolerated with a median treatment duration of 12.3 months 5
• Only 22-42% discontinued due to breakthrough bleeding, which was the most common side effect 4, 5

Practical Considerations for Slynd

Prescribe Slynd continuously (without placebo days) for endometriosis treatment, not in the standard 24/4 regimen 4, 5. This differs from its contraceptive indication.

Important contraindications and monitoring 3:

• Do not use in patients with kidney disease, liver disease, or adrenal insufficiency
• Check baseline potassium before starting if patient takes ACE inhibitors, ARBs, potassium-sparing diuretics, NSAIDs, or aldosterone antagonists
• Recheck potassium during the first month of treatment
• Drospirenone can increase serum potassium due to anti-mineralocorticoid properties

Alternative Medical Therapies

When progestins fail or are contraindicated:

GnRH agonists (Level A evidence):

• Equally effective as danazol when used ≥3 months 1
• Always add back-back therapy (estrogen/progestin) to prevent bone loss without reducing pain relief efficacy 1
• Appropriate even without surgical confirmation if detailed evaluation excludes other causes 1

Dienogest is another progestin with regulatory approval and has become widely used for long-term treatment across all endometriosis phenotypes 6.

Long-acting progestins are valid alternatives:

• Intrauterine levonorgestrel
• Subcutaneous etonogestrel 6

Surgical Considerations

Surgery provides significant pain reduction in the first 6 months, but 44% experience symptom recurrence within one year 1.

For severe endometriosis, medical treatment alone may not be sufficient 1. In these cases, combine surgical excision by a specialist with postoperative hormonal therapy.

Common Pitfalls to Avoid

1. Don't use standard 24/4 dosing of Slynd for endometriosis—prescribe continuously
2. Don't skip potassium monitoring in at-risk patients taking Slynd
3. Don't use GnRH agonists without add-back therapy for prolonged treatment
4. Don't assume combined oral contraceptives are superior—progestin-only options have better evidence for endometriosis specifically
5. Don't expect medical therapy to eradicate lesions—it reduces size and symptoms but doesn't eliminate disease 1

Treatment Algorithm

1. Start with progestin-only pill (Slynd 4 mg continuously, norethindrone acetate, or dienogest) as first-line
2. If inadequate response after 3 months, switch to alternative progestin or long-acting progestin
3. If still inadequate, escalate to GnRH agonist with add-back therapy
4. Consider surgery for severe disease, anatomic distortion, or medical treatment failure
5. Resume hormonal therapy postoperatively to reduce recurrence risk

The choice between specific progestins depends on contraindications (particularly renal/hepatic function for Slynd), patient preference, cost, and side effect profile. Slynd offers the advantage of being estrogen-free while providing effective pain relief, making it particularly useful in the 56% of endometriosis patients who have contraindications to estrogen-containing therapy 4.